Burn News and Research

RSS

Pepsico's initiative to reduce obesity, joins HWCF

PepsiCo, Inc., one of the world's largest food and beverage companies, today announced that it will expand its existing efforts to help reduce obesity in the United States by joining the Healthy Weight Commitment Foundation (HWCF).

6 Oct 2009

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

5 Oct 2009

Nationwide Children's Hospital study on burn injuries in kids

In the next 60 seconds, another child will be on his/her way to the hospital to be treated for serious burns; it happens more than 300 times a day in this country. Now, one of the largest studies ever done on burn injuries in kids is out from experts at Nationwide Children's Hospital and the results are mixed: while overall injuries are down, there are some kids who are still at serious risk.

5 Oct 2009

Burns: A common cause of pediatric injury

Burns are a common cause of pediatric injury worldwide, typically resulting from hot water, flames, hot surfaces, chemicals and electrical appliances. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, found that from 1990-2006 more than 2 million children younger than 21 were treated in hospital emergency departments for burn-related injuries.

5 Oct 2009

Update from BioCryst Pharmaceuticals regarding antiviral peramivir

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Office of the Secretary, Department of Health & Human Services (HHS) has issued "HHS Secretary's Declaration for the Use of the Public Readiness and Emergency Preparedness Act for the Influenza Antiviral Peramivir."

3 Oct 2009

Acute therapy and follow-up care of burn disease discussed

Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Ärzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease.

1 Oct 2009

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.

1 Oct 2009

Protection of front-line healthcare workers compromised

According to George Kappler, "If hospitals were subjected to the same protection standards as factories, many would have been shut down a long time ago." Those are tough words for healthcare workers to hear as they brace for an onslaught of H1N1 patients, but the CEO of Kappler, Inc., a 33-year veteran in the protective garment business, knows of what he speaks.

29 Sep 2009

NIH funds Brown University's Samoan genotyping project

Do some people have special "susceptibility" genes that make them vulnerable to obesity and diabetes, triggered by poor diet and less exercise?

28 Sep 2009

RWJF Nursing Scholarship Program helps alleviate nation's nursing shortage

Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been awarded Robert Wood Johnson Foundation (RWJF) funding through the RWJF New Careers in Nursing Scholarship Program.

25 Sep 2009

Practical and fun fitness tips for families

For parents who want to get their children away from the television or computer screen, Play It Again Sports has a simple solution: Make exercise a family affair.

23 Sep 2009

CSL Behring offers new dosage strength of Helixate FS in U.S.

Hemophilia A patients who require high doses of Helixate® FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength. CSL Behring announced today that this new dosage strength is available in the U.S., allowing many patients to reduce reconstitution time by eliminating the need to mix and pool multiple vials of Helixate FS.

22 Sep 2009

Tregs to set the pace of recovery after serious lung injury

After more than 50 experiments in mice, medical scientists at Johns Hopkins have mapped out the basic steps taken by a particular set of white blood cells in setting the pace of recovery after serious lung injury.

22 Sep 2009

FBC Acquisition commences tender offer to acquire all outstanding shares of Facet Biotech

Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.

22 Sep 2009

U.S. Department of Health & Human Services requests BioCryst for proposal for peramivir supply

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).

21 Sep 2009

HHS awards $77.2 million contract to BioCryst to complete Phase 3 development of peramivir

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.

21 Sep 2009

Postmenopausal women benefit as much from exercise as younger women

In two papers based on the experiments and published in recent months, UC Berkeley researchers report that postmenopausal women can achieve the same health benefits from regular, vigorous exercise as younger women do.

21 Sep 2009

Health Net is the national sponsor of the 2nd National Veterans Summer Sports Clinic

Health Net, Inc. (NYSE:HNT) is honored to serve as a national sponsor of the 2nd National Veterans Summer Sports Clinic, to be held Sept. 20–25, 2009, in San Diego.

19 Sep 2009

Wireless sensor being studied at the Virginia Commonwealth University Medical Center

A wireless, credit-card-sized sensor that can detect whether health care workers have properly washed their hands upon entering a patient's room is being studied at the Virginia Commonwealth University Medical Center. The device could greatly reduce the number of hospital acquired infections nationwide since most are transmitted through contact due to poor hand-washing practice.

17 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009